| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |